Test Price
2,800 AEDโ Home Collection Available
๐ Results in 3 to 4 Weeks
KMT2A Gene (Wiedemann-Steiner Syndrome) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM โ 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by DHA-licensed specialists.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Corporate Oversight: Test supervised by Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA ID: 9294403). All procedures comply with UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Test Overview & Methodology
The KMT2A gene test employs Next-Generation Sequencing (NGS) to identify pathogenic variants causing Wiedemann-Steiner syndromeโa rare genetic disorder characterized by dysmorphic features, developmental delay, and increased cancer risk. This comprehensive assay is essential for paediatricians, clinical geneticists, and oncologists managing at-risk families in the UAE.
| Feature | Our Test (KMT2A NGS) | Closest Alternative |
|---|---|---|
| Methodology | Full gene NGS (coding + flanking intronic regions) | Sanger sequencing (limited to exons 2, 3, 4 only) |
| Turnaround Time | 3 to 4 Weeks | 4 to 6 Weeks (fragmented analysis) |
| Diagnostic Yield | >99% sensitivity for point mutations and small indels | ~80% sensitivity, misses deep intronic variants |
Physician Insight & Safety Protocols
โThe KMT2A gene is a critical regulator of chromatin remodelling; mutations here can present with a wide phenotypic spectrum. This NGS-based test offers the resolution needed for precise diagnosis, but results must always be interpreted within the full clinical context, including dysmorphology examination and family pedigree analysis.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA ID: 9294403
Advisory Note
โ ๏ธ Medical Guidance: Do not discontinue any prescribed medication or alter treatment based solely on genetic test results. Always consult your supervising physician.
Patient Safety & Exclusion Criteria
- Exclusion: Recent blood transfusion (less than 2 weeks) may interfere with DNA purity; reschedule collection.
- Exclusion: Inadequate clinical history or absence of a genetic counselling session (mandatory per UAE genetic testing laws).
- Red Flag: If patient exhibits acute leukaemic symptoms (unexplained bruising, fever, severe bone pain), immediate haematology/oncology referral is requiredโthis test is not for acute diagnosis.
- Red Flag: For minors, consent must comply with Federal Decree-Law No. 4 of 2016 on Medical Liability; testing without parental/guardian consent is prohibited.
Patient FAQ & Clinical Guidance
1. What is the KMT2A gene test for?
Snippet: The KMT2A gene detects mutations causing Wiedemann-Steiner syndrome with 99.9% accuracy using Next-Generation Sequencing. It confirms clinical diagnosis, guides cancer surveillance, and helps family planning.
2. How is the sample collected and is home service available?
Snippet: A simple blood draw is collected at your home by our ISO-certified phlebotomy team using VIP Mobile Phlebotomy with temperature-controlled cold chain, available daily from 8 AM to 11 PM.
3. What are the clinical implications of a positive result?
Snippet: A positive KMT2A mutation confirms Wiedemann-Steiner syndrome, requiring specialist follow-up for development, congenital anomalies, and potential leukaemia screening protocols.
UAE Regulatory & Data Privacy Adherence
Data Protection & Legal Compliance
This genetic test service fully complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All data is processed in ISO 27001-certified facilities. Patient consent is obtained in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability. For minor patients, parental/guardian consent is mandatory. Genetic counselling is provided before and after testing, as required by UAE regulations.
Clinical & Logistical Metadata
| Test Name | KMT2A Gene (Wiedemann-Steiner Syndrome) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (3-5 ml in EDTA tube) or FTA card |
| Methodology Used | Next-Generation Sequencing (NGS) โ full gene coding and flanking intronic regions |
| ICD-10-CM Code | Q87.89, Z15.09, R62.50 |
| LOINC Code | 92915-6 |
| DHA Facility License & Address | Facility License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE โ DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
Preparation Required
["No specific fasting required", "Inform lab of recent blood transfusions (within 2 weeks)"]
Medically Reviewed by Dr. Lina Osama Zaki Quteineh
All content reviewed by qualified professionals for accuracy.
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians